Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Conatus Pharmaceuticals Inc (NASDAQ:CNAT)

4.03
Delayed Data
As of 4:00pm ET
 -0.05 / -1.23%
Today’s Change
1.73
Today|||52-Week Range
9.40
-23.53%
Year-to-Date
No recent news for Conatus Pharmaceuticals Inc.

Today’s Trading

Previous close4.08
Today’s open4.08
Day’s range4.01 - 4.23
Volume255,294
Average volume (3 months)316,420
Market cap$122.4M
Dividend yield--
Data as of 4:00pm ET, 11/21/2017

Growth & Valuation

Earnings growth (last year)-0.77%
Earnings growth (this year)+50.38%
Earnings growth (next 5 years)+74.00%
Revenue growth (last year)--
P/E ratioNM
Price/Sales149.38
Price/Book4.89

Competitors

 Today’s
change
Today’s
% change
BDSIBioDelivery Sciences...+0.05+2.22%
ALRNAileron Therapeutics...-0.28-2.28%
ADMPAdamis Pharmaceutica...-0.15-3.57%
OCXOncoCyte Corp-0.10-2.27%
Data as of 4:10pm ET, 11/21/2017

Financials

Next reporting dateMarch 15, 2018
EPS forecast (this quarter)-$0.17
Annual revenue (last year)$799.0K
Annual profit (last year)-$29.7M
Net profit margin-3,721.12%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Steven J. Mento
Executive VP, Chief Operating &
Financial Officer
Keith W. Marshall
Corporate headquarters
San Diego, California

Forecasts